GRANULES / NSE / Biotechnology & Drugs
Granules India
1Y Price Trend
Key Information
Recommendations
RatingStrong Buy
Target High804.05
Target Low433
Target Mean1.71
Target Median89.29
Risk Metrics
Overall RiskBalanced risk
Board Risk31.04
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Granules India to host investor meet in London on June 23 scanx.trade
Sushil Finance Starts Granules India at Buy with INR963 Price Target marketscreener.com
Add Granules India Ltd for Target Rs. 835 by Choice Institutional Equities Investment Guru
U.S. FDA issues VAI classification to Granules arm Virginia facility The Hindu
Granules Gets 4 USFDA Observations for US Facility Medical Dialogues
Granules India Climbs 2% as US Unit Bags Clean USFDA Inspection Nod Equitypandit
Granules India shares gain after US unit gets EIR from USFDA CNBC TV18
Granules India gains after arm receives EIR from USFDA for Virginia facility Business Standard
© SharekeyX | Rusaka Technologies 2024-2026

